Last Wednesday (11/6/2013), Reuters reported that the approval of a new cancer drug by Curis Inc. has stalled after a patient died while taking the drug.
Curis Inc. is a company that develops many new drugs used for in cancer treatment. In collaboration with other major drug companies, Curis created Erivedge, the only medication for